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A b s t r a c t
Repetitive transcranial magnetic stimulation (rTMS) induces changes in expression of proteins engaged in the activ-
ity of excitatory and inhibitory systems, restores these functions and suppresses the progression of disability in 
experimental autoimmune encephalitis (EAE). The structural type of TMS, the arrangement as theta burst stimu-
lation (TBS) has been applied as intermittent TBS (iTBS) and continuous TBS (cTBS) protocols to female adult DA 
rats. The animals were randomly divided into experimental groups: control group (C), group treated with complete 
Freund’s adjuvant (CFA), experimental autoimmune encephalomyelitis (EAE) group, group treated with iTBS post EAE 
immunization (EAE + iTBS), group treated with cTBS post EAE immunization (EAE + cTBS), group of healthy animals 
treated with iTBS or cTBS. Therapeutic protocols of iTBS or cTBS in all EAE groups of animals were performed starting 
from 14 days post immunization (dpi), for 10 days with time point decapitation at 24 dpi. After decapitation, spinal 
cords were analysed for BDNF and Ki67 expression. The results revealed reduced BDNF expression in the rat’s spinal 
cord of EAE animals in the stage of remission, which was associated with increased Ki67 and GFAP expressions. 
Decreased Iba 1 and BDNF expression, contrary to increased Iba 1 and Ki67 expression, suggests clustered microglia 
in the resolution phase of EAE. Enhanced GABA expression in spinal cord sections indicates higher GABA metabol-
ic turnover, and also GAD activity in astrocytes, or prominent activity of GABAergic neurons. Both TBS protocols 
induced advance BDNF expression; amongst iTBS application provoked elevating of BDNF and stabilizing of GFAP 
and Ki67 expressions. 
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Introduction
Major pathological processes in the central ner-
vous system (CNS) during multiple sclerosis (MS) 
are neuronal inflammation and neurodegeneration 
[31]. Developing techniques directed to protect neu-
ron structure and function; decreasing perivascular 
inflammation and supporting blood/brain barrier 
(BBB) integrity are promising in MS analogous CNS 
disease, i.e. experimental autoimmune encephalo-
myelitis (EAE). 
According to present knowledge of factors influ-
encing neuronal survival and repair during EAE, 
it has been shown that the proposed mechanism 
could be lymphoid imported and surrounding cells 
derived production of brain-derived neurotrophic 
factor (BDNF). Previously known as dorsal root gan-
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glion-derived, BDNF is known to enhance the neu-
ronal survival following CNS damage, to promote 
the growth of dendrites and axons, and the synapse 
formation. It is a major factor of the neurogenesis, 
the migration, and differentiation of neurons [5]. 
Besides cytokines, BDNF is also a  paracrine and 
autocrine signal molecule that interacts with spe-
cific receptors expressed on different cell types in 
the spinal cord. However, important aspects of its 
production in CNS auto-immunity such as cellular 
distribution and regulation remain unknown. Such 
data are important for the interpretation of the role 
of autoreactivity/inflammation in nonspecific CNS 
impairments, e.g. trauma or stroke, as well as for the 
evaluation of immunotherapy in MS. 
The role of BDNF in EAE is controversial. Pub-
lished data of mRNA in the lumbar spinal cord of 
EAE rats have shown that BDNF begins to upreg-
ulate 8 days post immunization (dpi), with a  peak 
level at 12 dpi and normalized expression at 16 dpi. 
The course of changes in BDNF is similar to changes 
in tumor necrosis factor α (TNF-α) and interferon γ 
(IFN-γ) [30]. Other data have shown that BDNF pro-
tein expression in the spinal cord was significantly 
increased at 12 dpi, and maintained at 15 dpi with 
no significant change in mRNA levels [45].
Recent studies revealed that an external magnet-
ic field, which is a consequence of transcranial mag-
netic stimulation (TMS) may affect BDNF content in 
the serum and cerebrospinal fluid (CSF). The results 
obtained from assessments of serum BDNF levels 
after TMS sessions are unclear. Some of them have 
found that repetitive TMS (rTMS) increases serum lev-
els of BDNF, while the other studies have found no 
effect [11,44]. Wang et al. reported that high-frequen-
cy rTMS increases serum BDNF levels and the affinity 
of BDNF for TrkB receptors, whereas low-frequency 
TMS reduces BDNF levels [42]. 
Alternating magnetic fields during rTMS stimu-
late cortical neurons spreading the effects spatially 
and temporarily. Neuronal activity similar to long-
term potentiation (LTP) and long-term depression 
(LTD) could support and create a favourable cellular 
environment for instigated neuroplasticity. Perform-
ing the activity in cortical zones it is forward to the 
lumbar spinal cord via corticospinal pathway activi-
ty. According to previously reported data, neuroplas-
ticity similar to LTP might be induced by intermit-
tent theta burst stimulation (iTBS) while continuous 
theta burst stimulation (cTBS) seems to induce the 
pattern of activity like LTD [4,10]. Neural plasticity 
induction with a  BDNF released from surrounding 
cells could support growth and survival of neurons 
suffering from inflammatory/mediated oedema and 
energy deficiency as well as free radical attack from 
the neuroinflammation-activated astrocyte/micro- 
glia/lymphocyte [27]. Increased levels of BDNF with-
in the dorsal root ganglion and spinal cord in EAE 
rats may facilitate myelin repair and remodel the 
synapses in the CNS. Anterograde transport of BDNF 
protein from the dorsal root ganglion to the dorsal 
horn of the spinal cord may promote neuroprotection. 
The importance of BDNF is accentuated by inter-
connections of BDNF and γ-aminobutyric acid (GABA) 
availability. It has been reported that the progressive 
failure of neuronal connectivity, particularly tran-
scallosal during MS development may be a result of 
impaired neuroinhibition [28]. Manyam et al. report-
ed that the levels of GABA in the cerebrospinal fluid 
of patients with MS are significantly lower compared 
to healthy subjects [26]. Such data could be defend-
ed by the accepted facts that GABAergic neurons in 
the neocortex are parts of neural circuits involved in 
behaviour, perception, memory, and consciousness. 
In MS patients as well as EAE animals, most of these 
functions have been getting worse [6,13,20,34,46].
Assuming that the release of BDNF in neural tis-
sue is stimulated by rTMS, such protocol could be 
promising for the therapy of MS. Neuroplasticity 
induced by LTP and LTD may induce the local brain 
changes at the molecular level, such as higher avail-
ability of BDNF that may decrease inflammation and 
support myelin repair. The target of the study was 
to analyse both iTBS or cTBS-induced changes of 
BDNF expression in lumbar spinal cords of EAE rats, 
to establish whether synthesized BDNF is originated 
from astrocytes or microglia and to correlate it with 
GABA availability due to the TMS protocol used.
Material and methods
All experimental procedures were performed 
according to decision No. 323-07-00622/2017-05 
obtained from the Ethics Committee for Animal 
Welfare and the Ministry of Agriculture and Environ-
mental Protection of the Republic of Serbia, which 
respects the rules of the European Parliament’s 
Directive 2010/63/EU on the protection of animals 
used for scientific purposes.
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Experiments were conducted on female Dark 
Agouti (DA) rats aged 10-14 weeks (150-200 g). The 
rats were housed in cages under standardized hous-
ing conditions (ambient temperature of 23 ±2ºC, rel-
ative humidity of 55 ±3% and a  light/dark cycle of 
13 h/11 h) with laboratory chow and water ad libitum. 
All the experiments were performed after 7 days’ 
period of adaptation to laboratory conditions and 
were carried out between 9 a.m. and 1 p.m. During 
the period of paralysis, for the purpose of welfare, 
water and food were down positioned to rats or giv-
en manually. 
The EAE was induced by a  subcutaneous (s.c.) 
injection of 0.1 ml solution of rat spinal cord tissue 
homogenate (50% w/v in saline) suspended in com-
plete Freund’s adjuvant (CFA) containing 1 mg/ml 
Mycobacterium tuberculosis (CFA; Sigma, St. Louis, 
MO, USA). The suspension was injected in animal’s 
right hind footpads. From the day of immunization, 
the rats were daily monitored and clinically scored. 
Theta burst stimulation was performed using 
a  MagStim Rapid2 device and a  25 mm figure-of-
eight coil (The MagStim Company, Whitland, Dyfed, 
UK). The procedures of rTMS were done according 
to Huang et al. [17]. The iTBS protocol consisted of 
20 trains of ten bursts (3 pulses at a  frequency of 
50 Hz) repeated at 5 Hz (lasting 192 s with 10 s 
intervals between trains) (iTBS groups), while the 
cTBS protocol consisted of a  single 40 s train of 
bursts repeated at 5 Hz (cTBS groups). Each block 
contained 600 pulses. Stimulus strength was 30% of 
the maximal stimulator output, just below the motor 
threshold value, which had been estimated as the 
visible contraction of upper limbs in all TBS-treat-
ed animals. During the TBS, the rats were slightly 
stressed and immobilized manually. The coil was 
gently relied on the rats’ head, centring the coil right 
above bregma [25]. 
Experimental procedure
The animals were randomly divided into experi-
mental groups: control group (C, n = 8); group treat-
ed with complete Freund’s adjuvant (CFA, n = 8), 
experimental autoimmune encephalomyelitis group 
(EAE, n = 8), group treated with iTBS post EAE immu-
nization (EAE + iTBS, n = 8), group treated with cTBS 
post EAE immunization (EAE + cTBS, n = 8), group 
of healthy animals treated with iTBS (iTBS, n = 8) or 
cTBS (cTBS, n = 8). Therapeutic protocols with iTBS 
or cTBS in all EAE groups were performed starting 
from 14 dpi, for 10 days with time point decapitation 
at 24 dpi. Healthy animals were treated with iTBS or 
cTBS for 10 days. 
Animals before the immunization as well as all 
animals before the decapitation were intraperitone-
ally anaesthetized (sodium-pentobarbital 45 mg/kg 
body weight – b.w.). The decapitations were per-
formed 24 h after the last TBS protocol or at the 
appropriate time point. Clinical evaluation of EAE was 
undertaken daily in a double-blind manner for up to 
24 dpi [14]. All immunized animals developed clini-
cal signs of the EAE that appeared between 10 and 
12 dpi and reached a peak at 11-14 dpi. Develop-
ment of the EAE signs was accompanied by body 
weight loss in all experimental groups and maximal 
weight loss coincided with paralysis. Two different 
TBS protocols, which had been reported to modulate 
cortical excitability in opposite directions, induced 
similar effects on the clinical score in EAE-induced 
animals. Duration of paralysis was notably shorter 
in EAE animals by 49% (iTBS) and 54% (cTBS) treat-
ment (p < 0.05, respectively), compared to the EAE 
group. 
Immunofluorescence
The experimental procedure for immunofluores-
cence staining was performed according to Dalmau 
and colleagues [7]. Spinal cords of each of three rats 
per group removed quickly and fixed in 4% parafor-
maldehyde (TAAB Laboratory Equipment, Aldermas-
ton, UK) in 0.1 M phosphate buffer (PBS; pH 7.4) 
for 12 h at 4°C. For cryoprotection, lumbar spinal 
cord tissue was transferred into the graded sucrose 
(10-30% in 0.1 M PBS, pH 7.4), frozen in 2-methyl 
butane, and kept at –80°C until sectioning on a cryo-
tome (CRIOCUT-E Reichert-Yung).
Sections of the spinal cord (25 µm thick) were col-
lected serially, mounted on superfrost glass slides, dried 
for 2 h at room temperature and stored at –20°C until 
staining. Initially, one series of slides of all experimental 
groups was incubated with primary polyclonal rabbit 
anti-BDNF antibody (1 : 50; Thermo Fisher Scientific, 
USA) overnight at 4°C, then secondary goat anti-rab-
bit Alexa Fluor 488 (1 : 500; Invitrogen, Carlsbad, USA) 
for 2 h at room temperature in the dark. Subsequently, 
the sections were incubated with primary monoclonal 
mouse anti-GFAP (1 : 200; Elabscience, USA) or mouse 
monoclonal anti-Iba 1 (1 : 50; Abcam, Germany) and 
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after that with secondary donkey anti-mouse Alexa 
Fluor 555 (1 : 250; Invitrogen, Carlsbad, USA) for 2 h at 
room temperature in the dark.
The next series of spinal cord sections was incu-
bated also with primary polyclonal rabbit anti-BD-
NF antibody (1 : 50; Thermo Fisher Scientific, USA) 
overnight at 4°C, but later with secondary donkey 
anti-rabbit Alexa Fluor 647 (1 : 500; Abcam, Germa-
ny) for 2 h at room temperature in the dark. After-
wards, spinal cord sections were incubated with 
primary polyclonal guinea pig anti-GABA (1 : 1000; 
Abcam, Germany) overnight at 4°C and then with 
secondary goat anti-guinea pig Alexa Fluor 488 
(1 : 500; Invitrogen, Carlsbad, USA) for 2 h at room 
temperature in the dark.
A  new series of slides was incubated with pri-
mary monoclonal rabbit anti-Ki67 antibody (1 : 300; 
Thermo Fisher Scientific, USA) overnight at 4°C, and 
later with secondary goat anti-rabbit Alexa Fluor 488 
(1 : 500; Invitrogen, Carlsbad, USA) for 2 h at room 
temperature in the dark. Afterward, slides were 
incubated with primary mouse monoclonal anti-
GFAP (1 : 200; Elabscience, USA) or mouse mono-
clonal anti-Iba 1 (1 : 50; Abcam, Germany) and then 
with secondary donkey anti-mouse Alexa Fluor 555 
(1 : 250; Invitrogen, Carlsbad, USA) for 2 h at room 
temperature in the dark. 
Finally, all slides were prepared on microscop-
ic slides using the Mowiol medium (Sigma Aldrich) 
and analysed under the confocal microscope (Zeiss 
Axiovert 200M, LSM 510 laser module).
Image processing and calculation  
of a colocalization coefficient
Three sections of three animals per group were used 
to verify fluorescence intensity. From each section, five 
random photomicrographs in the ventral horn regions 
of the spinal cord were captured at magnification 
(40× objective). Semi-quantitative fluorescence inten-
sity analysis was made using ImageJ software. Inten-
sities were expressed as a mean ± standard deviation 
(SD) of average grey values [41]. 
Quantitative colocalization analysis employs 
specialized algorithms which calculate a  number of 
respective coefficients, according to which colocal-
ization can be evaluated quantitatively [1]. As raw 
confocal images have high levels of background, they 
should be prepared to become suitable for reliable 
calculation of colocalization coefficients by correcting 
it. Colocalization is detected by correspondent anti-
bodies with diverse excitation spectra when staining 
of antigens visualized in different colours overlaps. 
Confocal microscopes provide resolution required 
for viewing colocalization in images clearly. This anal-
ysis can be explained as an existence of the signal at 
the same pixel location when examining multi-chan-
nel fluorescence microscopy images. The channels 
are generated by two different fluorochromes when 
respective antigens are visualized during examining 
of the same sample region. Observed colocalization of 
the antigens of interest gave valuable clues regarding 
their structural and functional characteristics. 
Colocalization presented as a plate of three imag-
es consisting of fluorescence for red and green chan-
nels, as well as a third merged image where the chan-
nels are combined (overlapping pixels turned yellow). 
The analysis is assisted by computer software, which 
estimates the degree of colocalization according to 
specialized algorithms within the selected region of 
interest (ROI). The analysis is performed for the eval-
uation of the colour components of the selected pair 
of channels. Images were imported into the Fiji ver-
sion of the free image processing software ImageJ. Fiji 
contains a number of pre-installed plugins including 
a  procedure for colocalization analysis, designated 
as coloc2, which calculates a  variety of colocaliza-
tion parameters such as the Pearson coefficient and 
Manders coefficients, both of which are based on 
pixel-intensity-correlation measurements. Numerical 
correlation parameters are recorded, as well as the 
2D intensity histogram for visualization of the cor-
relation between the two channels. Threshold objects 
are binarized followed by a watershed segmentation 
to separate adjacent entities. The results of coloc2 
derived intensity-based correlation analysis were cop-
ied into the same MS-Excel sheet and the different 
parameters, such as the Pearson coefficient or the 
Manders coefficients were multiplied with the colo-
calization fraction value. This results in a reduction of 
the pixel intensity-based correlation according to the 
percentage of object-based colocalization.
Statistical analysis 
Statistical data analysis was performed using 
one-way ANOVA and Tukey’s post hoc multiple tests 
(software GraphPad Prism, version 5.03). Values are 
presented as the means ± SD. Differences were con-
sidered statistically significant for p < 0.05.
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Fig. 1. Double fluorescence staining showing immunoreactivity for BDNF and GFAP in rats’ spinal cords. 
Bright grey (green in a  colour photograph) represents BDNF positivity, and darker grey (red in a  colour 
photograph) represents GFAP positivity. C – control group, EAE – rats (EAE) with experimental autoimmune 
encephalomyelitis, CFA – rats treated with complete Freund’s adjuvant, iTBS treatment on EAE animals (EAE 
+ iTBS) or on healthy animals (iTBS) and cTBS treatment on EAE animals (EAE + cTBS) or on healthy animals 
(cTBS). The photomicrographs were taken at magnification 400×. Scale bar corresponds to 200 µm.
 BDNF GFAP Merge
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Results
Photomicrographs of fluorescent immunoreactiv-
ity of BDNF and GFAP in the spinal cord tissue are 
shown in Figure 1, while analysed results are shown 
in Figure 2.
Decreased BDNF immunoreactivity was mea-
sured in EAE, but also in healthy animals treated with 
iTBS (Fig. 2A, p < 0.05). Application of iTBS or cTBS 
on EAE animals induced BDNF elevation, compared 
to the EAE group (p < 0.05). A  significant increase 
in GFAP was noted in the EAE group, compared to 
controls (p < 0.05), while cTBS treatment suppressed 
GFAP immunoreactivity, compared to the EAE group 
(Fig. 2B, p < 0.05). High positive coefficients of cor-
relations of BDNF and GFAP were detected in both 
iTBS/cTBS groups with EAE and these correlations 
were significantly higher compared to control groups 
as well as compared to the EAE group (Fig. 2C, 
p < 0.05). Both Manders coefficients M1 (BDNF) and 
M2 (GFAP) increased in EAE + iTBS compared to both 
control and EAE groups (Fig. 2D, p < 0.05, respective-
ly). Although neither BDNF nor GFAP immunoreac-
tivity in healthy animals treated with cTBS changed 
compared to controls, the correlation coefficient 
and Manders coefficient of colocalization notably 
increased (p < 0.05). 
Fig. 2. Effects of iTBS and cTBS on BDNF (A) and GFAP (B) expression in the spinal cords. Results were 
expressed as average grey value ± SD (n = 3). Changes of Pearson’s correlation coefficient (C) and Manders 
coefficients (D): M1 (BDNF) and M2 (GFAP). Values are presented as means ± SD. Differences were consid-
ered statistically significant for *p < 0.05 compared to controls and p < 0.05 compared to the EAE group.
80
60
40
20
0
 C CFA EAE EAE  iTBS EAE   cTBS
    + iTBS  + cTBS
B80
60
40
20
0
 C CFA EAE EAE  iTBS EAE   cTBS
    + iTBS  + cTBS
A
BD
N
F 
(a
ve
ra
ge
 g
ra
y 
va
lu
e)
G
FA
P 
(a
ve
ra
ge
 g
ra
y 
va
lu
e)
1.0
0.8
0.6
0.4
0.2
0.0
 C CFA EAE EAE  iTBS EAE    cTBS
    + iTBS  + cTBS
D1.0
0.5
0.0
–0.5
 C CFA EAE EAE  iTBS EAE   cTBS
    + iTBS  + cTBS
C
Pe
ar
so
n’
s 
co
rr
el
at
io
n 
co
effi
ci
en
t 
of
 B
D
N
F 
an
d 
G
FA
P
M
an
de
rs
 c
oe
ffi
ci
en
ts
M1 – BDNF          M2 – GFAP
135Folia Neuropathologica 2019; 57/2
TBS-induced BDNF expression in EAE
Fig. 3. Double fluorescence staining showing immunoreactivity for Ki67 and GFAP in rats’ spinal cords. 
Bright grey (green in a colour photograph) represents Ki67 positivity, and darker grey (red in a colour pho-
tograph) represents GFAP positivity. C – control group, EAE – rats (EAE) with experimental autoimmune 
encephalomyelitis, CFA – rats treated with complete Freund’s adjuvant, iTBS treatment on EAE animals 
(EAE + iTBS) or on healthy animals (iTBS) and cTBS treatment on EAE animals (EAE + cTBS) or on healthy 
animals (cTBS). The photomicrographs were taken at magnification 400×. Scale bar corresponds to 200 µm.
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Fluorescent immunoreactivities of Ki67 with 
GFAP and magnified photomicrograph in the spinal 
cord and the evaluations of obtained data are pre-
sented in Figures 3, 4 and 5.
Elevated Ki67 expression in the EAE group was 
associated with elevated GFAP, compared to controls 
(Fig. 5A, 5B, p < 0.05). Both therapeutic protocols (EAE 
+ iTBS and EAE + cTBS) induced decreased Ki67 and 
GFAP immunoreactivity, compared to the EAE group 
(p < 0.05). In these groups, both coefficients of correla-
tions between Ki67 and GFAP were not so prominent 
(Fig. 5C, D), but Manders coefficient indicates a high 
degree of Ki67 and GFAP molecules colocalization. In 
the healthy animals that were treated with iTBS/cTBS, 
a low level of both M1 (Ki67) and M2 (GFAP) coeffi-
cients of colocalization had been found. 
Double staining of BDNF with Iba 1 and data 
analyses of the spinal cord tissue are shown in Fig-
ures 6 and 7.
Contrary to elevated BDNF expression in the CFA 
group, it was decreased in EAE animals, compared to 
controls (Fig. 7A, p < 0.05). In addition, BDNF expres-
sion increased in iTBS-treated EAE animals com-
pared to controls (p < 0.05), and in EAE + iTBS and 
EAE + cTBS, compared to the EAE group (p < 0.05). 
Immunoreactivity of Iba 1 decreased in EAE, EAE + 
cTBS and cTBS animals, compared to controls (Fig. 
7B, p < 0.05). Treatment with iTBS in EAE animals 
induced elevation of Iba 1 expression, compared 
to controls, as well as compared to the EAE group 
(p < 0.05). The Pearson’s coefficients between 
BDNF and Iba 1, although at a  low level, indicates 
Fig. 4. Double fluorescence staining showing immunoreactivity for Ki67 and GFAP in the spinal cords of 
EAE animals. Bright grey (green in a colour photograph) represents Ki67 positivity, and darker grey (red in 
a colour photograph) represents GFAP positivity. The photomicrographs were taken at magnification 630×. 
Scale bar corresponds to 20 µm.
A
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D
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increased values in all experimental groups (except 
CFA) compared to controls (Fig. 7C, p < 0.05).
Fluorescent immunoreactivities of Ki67 with Iba 1 
and the estimated values are shown in Figures 8 and 9.
Expression of Ki67 together with Iba 1 is 
increased in EAE, compared to controls (p < 0.05), 
while iTBS treatment in EAE animals induced low-
er immunoreactivity of both molecules, compared 
to the EAE group (Fig. 9A, B, p < 0.05 respectively). 
Increased Ki67 in EAE + cTBS (p < 0.05) was not fol-
lowed by changed Iba 1 expression. The coefficients 
of correlations and colocalizations between Ki67 
and Iba 1 were not significant (Fig. 9C, D).
Double staining of BDNF and GABA and the confocal 
assessment of results are shown in Figures 10 and 11.
Decreased BDNF and increased GABA was noticed 
in the EAE group, compared to controls (Fig. 11A, B, 
p < 0.05 respectively). Both therapeutic protocols (iTBS 
or cTBS) induced opposite changes – increased BDNF 
and reduced GABA expression in EAE animals, com-
pared to the EAE group (p < 0.05). Expression of GABA 
in cTBS-treated healthy animals increased compared to 
controls (p < 0.05). Besides the low level of correlation, 
Manders coefficient of colocalization indicates diver-
gent colocalization in the control group which is con-
sistent only with EAE + iTBS group (Fig. 11C, D). Except 
for these two groups, all other groups showed a high 
level of BDNF and GABA colocalization. The statistical 
significance was obtained only for M2 (GABA) in EAE + 
cTBS compared to the EAE group of animals (p < 0.05).
Fig. 5. Effects of iTBS and cTBS on Ki67 (A) and GFAP (B) expression in the spinal cord. Results were 
expressed as average grey value ± SD (n = 3). Changes of Pearson’s correlation coefficient (C) and Manders 
coefficients (D): M1 (Ki67) and M2 (GFAP). Values are presented as means ± SD. Differences were consid-
ered statistically significant for *p < 0.05 compared to controls and p < 0.05 compared to the EAE group.
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Fig. 6. Double fluorescence staining showing immunoreactivity for BDNF and Iba 1 in rats’ spinal cords. 
Bright grey (green in a  colour photograph) represents BDNF positivity, and darker grey (red in a  colour 
photograph) represents Iba 1 positivity. C – control group, EAE – rats (EAE) with experimental autoimmune 
encephalomyelitis, CFA – rats treated with complete Freund’s adjuvant, iTBS treatment on EAE animals (EAE 
+ iTBS) or on healthy animals (iTBS) and cTBS treatment on EAE animals (EAE + cTBS) or on healthy animals 
(cTBS). The photomicrographs were taken at magnification 400×. Scale bar corresponds to 200 µm.
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Discussion
Decreased expression of BDNF in rats’ spinal 
cord tissue of EAE animals in the phase of remis-
sion is consistent with previously published reports 
of early-term changes in EAE development (Figs. 2 
and 7) [35]. Previously known as dorsal root gangli-
on-derived, BDNF is recognized to have functions in 
enhancements of neuronal survival following CNS 
damage: neurogenesis, the migration and differ-
entiation of neurons, the growth of dendrites and 
axons, and synapse formation [5]. It had been shown 
that peripheral chronic BDNF administration in mice 
enhanced neuron survival [38]. Initially, mRNA BDNF 
transcripts are translated as a  precursor protein, 
proBDNF, which may be secreted into the synaptic 
cleft [43]. There, BDNF is cleaved by metalloprotein-
ases and/or plasmin, giving rise to mature BDNF and 
the BDNF propeptide [22,32]. Then, BDNF is sorted 
into large dense core vesicles to be released from 
the regulated secretory pathway [29]. The decreased 
expression of BDNF in the remissive phase of EAE 
could be due to trafficking of BDNF to lysosomal 
degradation [8]. Also, decreased BDNF expression 
was associated with increased Ki67 and GFAP, the 
important marks of astrogliosis, which seems to be 
prolonged to the EAE remission (24 dpi). Assuming 
that microglia are not diffusely distributed in spinal 
cord parenchyma, decreased Iba 1 together with 
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Fig. 7. Effects of iTBS and cTBS on BDNF (A) and Iba 1 (B) expression in the spinal cord. Results were 
expressed as average grey value ± SD (n = 3). Changes of Pearson’s correlation coefficient (C) and Manders 
coefficients (D): M1 (BDNF) and M2 (Iba 1). Values are presented as means ± SD. Differences were consid-
ered statistically significant for *p < 0.05 compared to controls and p < 0.05 compared to the EAE group.
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Fig. 8. Double fluorescence staining showing immunoreactivity for Ki67 and Iba 1 in rats’ spinal cords. 
Bright grey (green in a colour photograph) represents Ki67 positivity, and darker grey (red in a colour pho-
tograph) represents Iba 1 positivity. C – control group, EAE – rats (EAE) with experimental autoimmune 
encephalomyelitis, CFA – rats treated with complete Freund’s adjuvant, iTBS treatment on EAE animals 
(EAE + iTBS) or on healthy animals (iTBS) and cTBS treatment on EAE animals (EAE + cTBS) or on healthy 
animals (cTBS). The photomicrographs were taken at magnification 400×. Scale bar corresponds to 200 µm.
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BDNF (Fig. 7) contrary to increased Iba 1 with Ki67 
(Fig. 9) expression indicates clustered microglia in 
the resolution phase of EAE. Colocalizations of these 
molecules in EAE animals did not reveal any dif-
ference, compared to control animals. At the same 
time, GABA expression increased in spinal cord tis-
sue sections, indicating higher GABA metabolic turn-
over, probably induced glutamic acid decarboxylase 
(GAD) activity in astrocytes, or prominent activity of 
GABAergic neurons (Fig. 11). Inflammation in EAE is 
related with calcium overload of neurons and mani-
fested process of excitotoxicity in which the release 
of glutamate is a crucial manifestation. Such chang-
es are the main events during the relapse phase of 
EAE, accordingly, increased GABA expression could 
indicate suppressed excitotoxicity and promoted 
inhibitory neuronal pathways [12]. 
Therapeutic procedures of both TBS induced 
important changes in investigated molecules 
expressions, such as BDNF elevation. Application of 
iTBS induced increasing of BDNF, compared to EAE 
animals, together with normalized GFAP and Ki67 
(Figs. 2 and 5). Resting microgliosis with lower Ki67 
in EAE + iTBS indicates clustered microglia with 
less mitotic activity. This is in accordance with large 
Manders coefficient of colocalization for BDNF and 
Iba 1 (Fig. 7D). It has been shown that BDNF sup-
port late hippocampal LTP through a TrkB-dependent 
mechanism. Panja et al. showed that LTP consolida-
tion in the dentate gyrus is mediated on a  trans-
lational level by sustained BDNF-TrkB signalling to 
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Fig. 9. Effects of iTBS and cTBS on Ki67 (A) and Iba 1 (B) expression in the spinal cords. Results were 
expressed as average grey value ± SD (n = 3). Changes of Pearson’s correlation coefficient (C) and Manders 
coefficients (D): M1 (Ki67) and M2 (Iba 1). Values are presented as means ± SD. Differences were consid-
ered statistically significant for *p < 0.05 compared to controls and p < 0.05 compared to the EAE group.
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Fig. 10. Double fluorescence staining showing immunoreactivity for BDNF and GABA in rats’ spinal cords. 
Darker grey (red in a  colour photograph) represents BDNF positivity, and bright grey (green in a  colour 
photograph) represents GABA positivity. C – control group, EAE – rats (EAE) with experimental autoimmune 
encephalomyelitis, CFA – rats treated with complete Freund’s adjuvant, iTBS treatment on EAE animals (EAE 
+ iTBS) or on healthy animals (iTBS) and cTBS treatment on EAE animals (EAE + cTBS) or on healthy animals 
(cTBS). The photomicrographs were taken at magnification 400×. Scale bar corresponds to 200 µm.
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MAP-kinase-interacting kinase [33]. Advertising of 
LTP induced by iTBS is expected to trigger gluta-
matergic neurotransmission, which is crucial in the 
spinal cord. Promotion of BDNF neurotrophic effects 
post iTBS in EAE may support the survival of neu-
rons in the dorsal horns as well as in the dorsal root 
ganglion [15]. It had been shown that patients with 
amyotrophic lateral sclerosis exhibit reduced serum 
levels of BDNF after the application of low-frequency 
rTMS to the motor cortex while the high-frequency 
stimulation increases BDNF levels in the blood plas-
ma of patients with depression [3,44]. Our results 
are consistent in beneficial effects of both applied 
TMS protocols expressed as elevated BDNF in lum-
bar ventral horn regions of rats spinal cord.
BDNF binds TrkB with a high affinity [40]. Phos-
phorylation of residues at the cytoplasmic autoreg-
ulatory loop of the catalytic domain is considered 
a critical step in TrkB activation, followed by phos-
phorylation of other tyrosine residues triggering the 
MAPK/AKT pathways and activation of the signal-
ling pathway through phospholipase C γ [16,37]. It 
had been shown that BDNF-induced TrkB activation 
is able to promote the survival of cultured embry-
onic mesencephalic dopaminergic neurons [18,21], 
cholinergic neurons in the basal forebrain [2], retinal 
ganglion cells [19], and also cortical embryonic neu-
rons [36]. 
There are two primary rTMS treatment regimes: 
low-frequency rTMS, which is defined by stimulation 
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Fig. 11. Effects of iTBS and cTBS on BDNF (A) and GABA (B) expression in the spinal cords. Results were 
expressed as average grey value ± SD (n = 3). Changes of Pearson’s correlation coefficient (C) and Manders 
coefficients (D): M1 (BDNF) and M2 (GABA). Values are presented as means ± SD. Differences were consid-
ered statistically significant for *p < 0.05 compared to controls and p < 0.05 compared to the EAE group.
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at frequencies lower than 1Hz, and high-frequency 
rTMS, which is defined by stimulation at frequencies 
higher than 5 Hz. Low-frequency rTMS reduces neuro-
nal excitability, where a high-frequency rTMS increases 
cortical excitability [24]. In hippocampal cell cultures, 
low-intensity TMS (1.14 T, 1 Hz) results in dendritic 
sprouting (axon growth) and growth and increases the 
density of synaptic contacts. By contrast, high-intensity 
stimulation (1.55 T, 1 Hz) has devastating effects that 
result in decreased numbers of dendrites and axons, 
the presence of neuronal lesions, and a  diminished 
number of synapses. Both results are associated with 
the BDNF-TrkB signalling system [23]. 
Long-lasting positive effects of rTMS seem to act 
at the single neuron, neural network (mutual exci-
tation and inhibition of cerebral regions), synaptic, 
and/or molecular (gene expression, enzyme activi-
ty, and neuromodulation) levels. Numerous studies 
have unambiguously demonstrated that TMS stim-
ulate and induce gene expression and enhance the 
production of a  number of signal molecules [39]. 
In an animal model of spinal cord injury, under the 
influence of TMS, astrocytes increased the ability to 
migrate to a zone of the lesion, which might be due 
to the activation of MEK1,2/ ERK mitotic pathways, 
and enhanced expressions of several genes [9]. 
In our experiment, changes in molecular expres-
sions indicate beneficial effects of TBS/increased 
BDNF together with lower GFAP and Ki67, as well as 
GABA depletion. At the moment we could speculate 
influenced GAD activity in astrocytes, and/or modu-
lated activity of GABAergic neurons. Effects of both 
TBS protocols suggest the TBS as potential thera-
peutic protocols in multiple sclerosis.
Acknowledgements
This work was supported by the University of 
Defence, Project No. MFVMA/04/19-21 and Ministry 
of Education and Science Republic of Serbia (grant 
number 41018).
Disclosure
The authors report no conflict of interest. 
References
1. Agnati LF, Fuxe K, Torvinen M, Genedani S, Franco R, Watson S, 
Nussdorfer GG, Leo G, Guidolin D. New methods to evaluate colo-
calization of fluorophores in immunocytochemical preparations 
asexemplified by a study on A2A and D2 receptors in Chinese 
hamster ovary cells. J Histochem Cytochem 2005; 53: 941-953.
2. Alderson RF, Curtis R, Alterman AL, Lindsay RM, DiStefano PS. 
Truncated TrkB mediates the endocytosis and release of BDNF 
and neurotrophin-4/5 by rat astrocytes and schwann cells in 
vitro. Brain Res 2000; 871: 210-222.
3. Angelucci F, Oliviero A, Pilato F, Saturno E, Dileone M, Versace V, 
Musumeci G, Batocchi AP, Tonali PA, Di Lazzaro V. Transcranial 
magnetic stimulation and BDNF plasma levels in amyotrophic 
lateral sclerosis. Neuroreport 2004; 15: 717-720.
4. Aydin-Abidin S, Trippe J, Funke K, Eysel UT, Benali A. High- and 
lowfrequency repetitive transcranial magnetic stimulation dif-
ferentially activates c-Fos and zif268 protein expression in the 
rat brain. Exp Brain Res 2008; 188: 249e261.
5. Baquet ZC, Gorski Jessica A, Jones KR. Early striatal dendrite 
deficits followed by neuron loss with advancedage in the 
absence of anterograde cortical brain derived neurotrophic 
factor. J Neurosci 2004; 24: 4250-4258. 
6. Calabrese M, Filippi M, Gallo P. Cortical lesions in multiple scle-
rosis. Nat Rev Neurol 2010; 6: 438-444. 
7. Dalmau I, Vela JM, González B, Finsen B, Castellano B. Dynam-
ics of microglia in the developing rat brain. J Comp Neurol 
2003; 458: 144-157.
8. Evans SF, Irmady K, Ostrow K, Kim T, Nykjaer A, Saftig P, Blobel C, 
Hempstead BL. Neuronal brain-derived neurotrophic factor is 
synthesized in excess, with levels regulated by sortilin-medi-
ated trafficking and lysosomal degradation. J Biol Chem 2011; 
286: 29556-29567. 
9. Fang ZY, Li Z, Xiong L, Huang J, Huang XL. Magnetic stimulation 
influences injury-induced migration of white matter astro-
cytes. Electromagn Biol Med 2010; 29: 113-121. 
10. Funke K, Benali A. Modulation of cortical inhibition by rTMS 
– findings obtained from animal models. J Physiol 2011; 589: 
4423e4435.
11. Gedge L, Beaudoin A, Lazowski L, du Toit R, Jokic R, Milev R. Effects 
of electroconvulsive therapy and repetitive transcranial magnet-
ic stimulation on serum brain-derived neurotrophic factor levels 
in patients with depression. Front Psychiatry 2012; 3: 12.
12. Gilani AA, Dash RP, Jivrajani MN, Thakur SK, Nivsarkar M. Eval-
uation of GABAergic transmission modulation as a novel func-
tional target for management of multiple sclerosis: exploring 
inhibitory effect of GABA on glutamate-mediated excitotoxici-
ty. Adv Pharmacol Sci 2014; 2014: 632376.
13. Gonzalez-Burgos G, Hashimoto T, Lewis DA. Inhibition and tim-
ing in cortical neural circuits. Am J Psychiatry 2007; 164: 12.
14. Hammer LA, Zagon IS, McLaughlin PJ. Improved clinical behav-
ior of established relapsing-remitting experimental autoim-
mune encephalomyelitis following treatment with endogenous 
opioids: Implications for the treatment of multiple sclerosis. 
Brain Res Bull 2015; 112: 42-51.
15. Hofer MM, Barde YA. Brain-derived neurotrophic factor pre-
vents neuronal death in vivo. Nature 1988; 331: 261-262.
16. Huang EJ, Wilkinson GA, Fariñas I, Backus C, Zang K, Wong 
SL, Reichardt LF. Expression of Trk receptors in the developing 
mouse trigeminal ganglion: in vivo evidence for NT-3 activation 
of TrkA and TrkB in addition to TrkC. Development 1999; 126: 
2191-2203.
17. Huang YZ, Chen RS, Rothwell JC, Wen HY. The after-effect of 
human theta burst stimulation is NMDA receptor dependent. 
Clin Neurophysiol 2007; 118: 1028-1032.
145Folia Neuropathologica 2019; 57/2
TBS-induced BDNF expression in EAE
18. Hyman C, Juhasz M, Jackson C, Wright P, Ip NY, Lindsay RM. 
Overlapping and distinct actions of the neurotrophins BDNF, 
NT-3, and NT-4/5 on cultured dopaminergic and GABAergic 
neurons of the ventral mesencephalon. J Neurosci 1994; 14: 
335-347.
19. Johnson RA, Lam M, Punzo AM, Li H, Lin BR, Ye K, Mitchell GS, 
Chang Q. 7,8-dihydroxyflavone exhibits therapeutic efficacy in 
a mouse model of Rett syndrome. J Appl Physiol (1985) 2012; 112: 
704-710. 
20. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cyto-
kine mRNA expression in the central nervous system of mice with 
experimental autoimmune encephalomyelitis reveals that IL-10 
mRNA expression correlates with recovery. J Immunol 1992; 149: 
2496-2505.
21. Knusel B, Gao H, Okazaki T, Yoshida T, Mori N, Hefti F, Kaplan DR. 
Ligand-induced down-regulation of Trk messenger RNA, protein 
and tyrosine phosphorylation in rat cortical neurons. Neurosci-
ence 1997; 78: 851-862.
22. Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell sur-
vival by secreted proneurotrophins. Science 2001; 294: 1945-1948.
23. Ma J, Zhang Z, Su Y, Kang L, Geng D, Wang Y, Luan F, Wang M, Cui 
H. Magnetic stimulation modulates structural synaptic plasticity 
and regulates BDNF-TrkB signal pathway in cultured hippocampal 
neurons. Neurochem Int 2013; 62: 84-91. 
24. Maeda F, Keenan JP, Tormos JM, Topka H, Pascual-Leone A. Inter-
individual variability of the modulatory effects of repetitive tran-
scranial magnetic stimulation on cortical excitability. Exp Brain 
Res 2000; 133: 425-430.
25. Mancic B, Stevanovic I, Ilic TV, Djuric A, Stojanovic I, Milanovic S, 
Ninkovic M. Transcranial theta-burst stimulation alters GLT-1 and 
vGluT1 expression in rat cerebellar cortex. Neurochem Int 2016; 
100: 120-127. 
26. Manyam NV, Katz L, Hare TA, Gerber JC 3rd, Grossman MH. Levels 
of gamma-aminobutyric acid in cerebrospinal fluid in various neu-
rologic disorders. Arch Neurol 1980; 37: 352-355.
27. Martins LF, Costa RO, Pedro JR, Aguiar P, Serra SC, Teixeira FG, 
Sousa N, Salgado AJ, Almeida RD. Mesenchymal stem cells secre-
tome-induced axonal outgrowth is mediated by BDNF. Sci Rep 
2017; 7: 4153. 
28. Massella A, D’Intino G, Fernández M, Sivilia S, Lorenzini L, Giatti S, 
Melcangi RC, Calzà L, Giardino L. Gender effect on neurodegenera-
tion and myelin markers in an animal model for multiple sclerosis. 
BMC Neurosci 2012; 13: 12.
29. Matsuda N, Lu H, Fukata Y, Noritake J, Gao H, Mukherjee S, Nemo- 
to T, Fukata M, Poo MM. Differential activity-dependent secretion 
of brain-derived neurotrophic factor from axon and dendrite. 
J Neurosci 2009; 29: 14185-14198.
30. Muhallab S, Lundberg C, Gielen AW, Lidman O, Svenningsson A, 
Piehl F, Ollson T. Differential expression neurotrophic factors and 
inflammatory cytokines by myelin basic protein-specific and oth-
er recruited T cells infiltrating the central nervous system during 
experimental autoimmune encephalomyelitis. Scand J Immunol 
2002; 55: 264-273.
31. Musella A, Gentile A, Rizzo FR, De Vito F, Fresegna D, Bullitta S, 
Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Cento- 
nze D, Mandolesi G. Interplay between age and neuroinflamma-
tion in multiple sclerosis: Effects on motor and cognitive functions. 
Front Aging Neurosci 2018; 10: 238.
32. Pang PT, Lu B. Regulation of late-phase LTP and long-term memory 
in normal and aging hippocampus: role of secreted proteins tPA 
and BDNF. Ageing Res Rev 2004; 3: 407-430.
33. Panja D, Kenney JW, D’Andrea L, Zalfa F, Vedeler A, Wibrand K, 
Fukunaga R, Bagni C, Proud CG, Bramham CR. Two-stage trans-
lational control of dentate gyrus LTP consolidation is mediated 
by sustained BDNF-TrkB signaling to MNK. Cell Rep 2014; 9: 1430-
1445. 
34. Paparrigopoulos T, Ferentinos P, Kouzoupis A, Koutsis G, Papad-
imitriou GN. The neuropsychiatry of multiple sclerosis: focus on 
disorders of mood, affect and behaviour. Int Rev Psychiatry 2010; 
22: 14-21. 
35. Park H, Poo MM. Neurotrophin regulation of neural circuit devel-
opment and function. Nat Rev Neurosci 2013; 14: 7-23. 
36. Polleux F, Whitford KL, Dijkhuizen PA, Vitalis T, Ghosh A. Control 
of cortical interneuron migration by neurotrophins and PI3-kinase 
signaling. Development 2002; 129: 3147-3160.
37. Rantamäki T, Hendolin P, Kankaanpää A, Mijatovic J, Piepponen P, 
Domenici E, Chao MV, Männistö PT, Castrén E. Pharmacological-
ly diverse antidepressants rapidly activate brain-derived neuro-
trophic factor receptorTrkB and induce phospholipase-Cgamma 
signaling pathways in mouse brain. Neuropsychopharmacol 2007; 
32: 2152-2162.
38. Schmidt HD, Duman RS. Peripheral BDNF produces antidepres-
sant-like effects in cellular and behavioral models. Neuropsycho-
pharmacol 2011; 36: 550. 
39. Simis M, Adeyemo BO, Medeiros LF, Miraval F, Gagliardi RJ, Fregni 
F. Motor cortex-induced plasticity by noninvasive brain stimula-
tion: a comparison between transcranial direct current stimula-
tion and transcranialmagneticstimulation. Neuroreport 2013; 24: 
973-975.
40. Soppet D, Escandon E, Maragos J, Middlemas DS, Reid SW, Blair J, 
Burton LE, Stanton BR, Kaplan DR, Hunter T, Nikolics K, Para- 
da LF. The neurotrophic factors brain-derived neurotrophic factor 
and neurotrophin-3 are ligands for the trkB tyrosine kinase recep-
tor. Cell 1991; 65: 895-903.
41. Sze SCW, Wong CKC, Yung KKL. Modulation of the gene expres-
sion of N-methyl-D-aspartate receptor NR2B subunit in the rat 
neostriatum by a single dose of specific antisense oligodeoxynu-
cleotide. Neurochem Int 2001; 39: 319-327.
42. Wang HY, Crupi D, Liu J, Stucky A, Cruciata G, Di Rocco A. Repetitive 
transcranial magnetic stimulation enhances BDNF-TrkB signaling 
in both brain and lymphocyte. J Neurosci 2011; 31: 11044-11054.
43. Yang J, Siao CJ, Nagappan G, Marinic T, Jing D, McGrath K, 
Chen ZY, Mark W, Tessarollo L, Lee FS, Lu B, Hempstead BL. Neuro-
nal release of proBDNF. Nat Neurosci 2009; 12: 113-115. 
44. Yukimasa T, Yoshimura R, Tamagawa A, Uozumi T, Shinkai K, 
Ueda N. High-frequency repetitive transcranial magnetic stimu-
lation improves refractory depression by influencing catechola-
mine and brain-derived neurotrophicfactors. Pharmacopsychiatry 
2006; 39: 52-59. 
45. Zhu W, Frost EE, Begum F, Vora P, Au K, Gong Y, MacNeil B, Pil-
lai P, Namaka M. The role of dorsal root ganglia activation 
and brain-derived neurotrophic factor in multiple sclerosis. 
J Cell Mol Med 2012; 16: 1856-1865.
46. Zipoli V, Goretti B, Hakiki B, Siracusa G, Sorbi S, Portaccio E, Ama- 
to MP. Cognitive impairment predicts conversion to multiple scle-
rosis in clinically isolated syndromes. Mult Scler 2010; 16: 62-67.
